Toxicity of sorafenib: clinical and molecular aspects.
Blanchet B, Billemont B, Barete S, Garrigue H, Cabanes L, Coriat R, Francès C, Knebelmann B, Goldwasser F.
Blanchet B, et al.
Expert Opin Drug Saf. 2010 Mar;9(2):275-87. doi: 10.1517/14740330903510608.
Expert Opin Drug Saf. 2010.
PMID: 20078249
Review.